Endometrial cancer (EC) develops in an environment strongly modulated by the immune system, and changes in dendritic cells (mDCs and pDCs), and monocytes (MO) expressing PD-L1 and PD-L2 may influence disease progression. This evidence concerns the gene CD274 and endometrial cancer.